(Q47831731)

6 February 2018

title

Direct treatment costs for patients with lung cancer from first recurrence to death in france. (English)

1 reference

6 February 2018

author name string

Anne-Chantal Braud

1

1 reference

6 February 2018

Christine Lévy-Piedbois

2

1 reference

6 February 2018

Pascal Piedbois

3

1 reference

6 February 2018

Youri Piedbois

4

1 reference

6 February 2018

Alain Livartovski

5

1 reference

6 February 2018

Béatrice Le Vu

6

1 reference

6 February 2018

Jean Trédaniel

7

1 reference

6 February 2018

François Reboul

8

1 reference

6 February 2018

Yvelise Brewer

9

1 reference

6 February 2018

Said Talbi

10

1 reference

6 February 2018

François Blanchon

11

1 reference

6 February 2018

Britta Paschen

12

1 reference

6 February 2018

Isabelle Durand-Zaleski

13

1 reference

6 February 2018

publication date

1 January 2003

1 reference

6 February 2018

published in

PharmacoEconomics

1 reference

6 February 2018

volume

21

1 reference

6 February 2018

issue

9

1 reference

6 February 2018

page(s)

671-679

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.2165/00019053-200321090-00005

exact match

0 references

cites work

Treatment pathways, resource use and costs in the management of small cell lung cancer

1 reference

12 December 2020

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

12 December 2020

Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model

1 reference

12 December 2020

The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer

1 reference

12 December 2020

Cost of patient follow-up after potentially curative lung cancer treatment.

1 reference

12 December 2020

Costs of care associated with non-small-cell lung cancer in a commercially insured cohort

1 reference

12 December 2020

A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma

1 reference

12 December 2020

Treatment of large airway obstruction in lung cancer using expandable metal stents inserted under direct vision via the fibreoptic bronchoscope

1 reference

12 December 2020

The treatment of recurrent brain metastases with stereotactic radiosurgery

1 reference

12 December 2020

Economic issues in lung cancer: a review

1 reference

12 December 2020

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

12 December 2020

The hospital costs of treating lung cancer in the United Kingdom

1 reference

12 December 2020

"Salvage" radiation therapy for intrathoracic small cell carcinoma of the lung progressing on combination chemotherapy

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Diagnostic and therapeutic approaches to lung cancer in Canada and their costs

1 reference

12 December 2020

Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases.

1 reference

12 December 2020

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

12 December 2020

The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer

1 reference

12 December 2020

Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma

1 reference

12 December 2020

10.2165/00019053-200321090-00005

Identifiers

DOI

1 reference

6 February 2018

Dimensions Publication ID

0 references

1 reference

6 February 2018